IBEX (IBEX) Competitors $25.69 -0.14 (-0.54%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$24.99 -0.70 (-2.72%) As of 02/21/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends IBEX vs. PHR, QBTS, STGW, PINC, UPBD, LZ, TASK, VVX, GB, and FVRRShould you be buying IBEX stock or one of its competitors? The main competitors of IBEX include Phreesia (PHR), D-Wave Quantum (QBTS), Stagwell (STGW), Premier (PINC), Upbound Group (UPBD), LegalZoom.com (LZ), TaskUs (TASK), V2X (VVX), Global Blue Group (GB), and Fiverr International (FVRR). These companies are all part of the "business services" industry. IBEX vs. Phreesia D-Wave Quantum Stagwell Premier Upbound Group LegalZoom.com TaskUs V2X Global Blue Group Fiverr International Phreesia (NYSE:PHR) and IBEX (NASDAQ:IBEX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends. Which has more volatility and risk, PHR or IBEX? Phreesia has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, IBEX has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Does the MarketBeat Community believe in PHR or IBEX? Phreesia received 114 more outperform votes than IBEX when rated by MarketBeat users. Likewise, 68.06% of users gave Phreesia an outperform vote while only 41.77% of users gave IBEX an outperform vote. CompanyUnderperformOutperformPhreesiaOutperform Votes14768.06% Underperform Votes6931.94% IBEXOutperform Votes3341.77% Underperform Votes4658.23% Which has stronger earnings and valuation, PHR or IBEX? IBEX has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than IBEX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhreesia$356.30M4.60-$136.88M-$1.47-19.18IBEX$521.73M0.65$33.65M$2.1312.06 Do institutionals and insiders believe in PHR or IBEX? 92.1% of Phreesia shares are owned by institutional investors. Comparatively, 81.2% of IBEX shares are owned by institutional investors. 5.8% of Phreesia shares are owned by company insiders. Comparatively, 6.7% of IBEX shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is PHR or IBEX more profitable? IBEX has a net margin of 7.08% compared to Phreesia's net margin of -20.43%. IBEX's return on equity of 25.29% beat Phreesia's return on equity.Company Net Margins Return on Equity Return on Assets Phreesia-20.43% -32.78% -22.37% IBEX 7.08%25.29%13.16% Do analysts prefer PHR or IBEX? Phreesia currently has a consensus price target of $31.15, indicating a potential upside of 10.49%. IBEX has a consensus price target of $25.00, indicating a potential downside of 2.69%. Given Phreesia's stronger consensus rating and higher possible upside, equities research analysts clearly believe Phreesia is more favorable than IBEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phreesia 0 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 3.00IBEX 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor PHR or IBEX? In the previous week, Phreesia had 6 more articles in the media than IBEX. MarketBeat recorded 15 mentions for Phreesia and 9 mentions for IBEX. IBEX's average media sentiment score of 0.32 beat Phreesia's score of 0.30 indicating that IBEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IBEX 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPhreesia and IBEX tied by winning 9 of the 18 factors compared between the two stocks. Get IBEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBEX vs. The Competition Export to ExcelMetricIBEXData processing & preparation IndustryBusiness SectorNASDAQ ExchangeMarket Cap$338.90M$4.29B$7.84B$8.99BDividend YieldN/A2.63%2.21%3.85%P/E Ratio12.0670.3233.3018.54Price / Sales0.6519.5764.2279.35Price / Cash8.3734.8932.3137.40Price / Book3.116.575.424.64Net Income$33.65M$38.21M$187.27M$245.69M7 Day Performance-5.90%-3.24%-2.92%-2.67%1 Month Performance17.84%5.33%-1.50%-2.16%1 Year Performance82.72%16.89%18.50%12.90% IBEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBEXIBEX1.9291 of 5 stars$25.69-0.5%$25.00-2.7%+78.4%$338.90M$521.73M12.0630,000Insider TradePHRPhreesia4.3976 of 5 stars$29.80-0.7%$31.15+4.5%+12.0%$1.73B$356.30M-20.271,438Insider TradeQBTSD-Wave Quantum0.9664 of 5 stars$6.38-1.9%$6.71+5.2%+299.2%$1.72B$9.42M-15.183Options VolumeGap UpSTGWStagwell3.3452 of 5 stars$6.50-3.7%$8.50+30.8%-7.5%$1.71B$2.71B22.5013,000Analyst UpgradePINCPremier3.0015 of 5 stars$17.77-1.5%$20.50+15.4%-12.6%$1.71B$1.35B-177.682,900UPBDUpbound Group4.3178 of 5 stars$29.45-1.1%$39.17+33.0%-17.3%$1.61B$3.99B20.3112,970Earnings ReportAnalyst ForecastNews CoverageLZLegalZoom.com1.9632 of 5 stars$9.18+1.1%$9.06-1.3%-11.2%$1.59B$678.84M70.621,190TASKTaskUs1.3921 of 5 stars$15.90+1.9%$17.00+6.9%+17.7%$1.42B$955.01M26.9548,200Upcoming EarningsNews CoverageVVXV2X3.8141 of 5 stars$44.88-3.4%$66.50+48.2%+7.9%$1.42B$4.20B160.3016,000GBGlobal Blue Group1.9224 of 5 stars$6.58-2.9%$6.00-8.9%+55.6%$1.31B$458.29M31.351,939Upcoming EarningsNews CoverageFVRRFiverr International3.8228 of 5 stars$33.27+1.3%$32.30-2.9%-0.7%$1.29B$361.38M127.98790Analyst ForecastOptions VolumeNews Coverage Related Companies and Tools Related Companies PHR Competitors QBTS Competitors STGW Competitors PINC Competitors UPBD Competitors LZ Competitors TASK Competitors VVX Competitors GB Competitors FVRR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IBEX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.